Company & Sponsor Intelligence
Brown University
Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.
Request enterprise analysis →Indexed trials3
Recruiting0
Completed2
Countries1
Therapeutic footprint
anxietydepressionparkinsons
Indexed studies
NCT01382342The Effect of Rasagiline on Cognition in Parkinson's Disease
parkinsons · United StatesPHASE4
parkinsons · United StatesPHASE4
NCT01831362Dismantling Mindfulness: Contributions of Attention vs. Acceptance
depression · United StatesNA
depression · United StatesNA
NCT06051084Investigating How the Brain Processes Different Experiences
anxiety · United StatesNA
anxiety · United StatesNA
Intelligence layer updated: 2026-10-15 06:14:04.252491+00:00
Enterprise intelligence
Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.
Request comparative intelligence →